Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Comparing reduced port laparoscopic gastrectomy to traditional methods for gastric cancer

Official title: Comparison the Short and Long-term Outcome of Patients With Gastric Cancer Who Underwent Reduced Port Laparoscopic Gastrectomy With Patients Underwent Traditional Laparoscopic Gastrectomy

Run by Nanchong Central Hospital · NCT04295473 · Data updated 2026-11-12

This study tests if a new way of doing stomach surgery with fewer small cuts is safer and works better for people with gastric cancer compared to the usual method.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment160 (estimated)
SponsorNanchong Central Hospital
Government
Drugs / interventionschemotherapy, radiation
Locations1 site (Nanchong, Sichuan)
StatusRecruiting
StartedMarch 2, 2020
Main results expectedMarch 1, 2027
Study endsMarch 1, 2027
Registry record updatedMay 21, 2025
Trial IDNCT04295473 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with histologically confirmed adenocarcinoma of the stomach at stages T1-T4 and an Eastern Cooperative Oncology Group performance status of 0 or 1.

Probably not a fit

Patients with distant metastasis, significant oesophageal invasion, or those who have received prior chemotherapy or radiation therapy for other malignancies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and outcomes of reduced port laparoscopic gastrectomy in patients with gastric cancer compared to traditional laparoscopic gastrectomy. It aims to assess both short-term outcomes, such as surgical complications and postoperative nutrition, and long-term outcomes, including survival rates. The study involves patients with histologically confirmed adenocarcinoma of the stomach and will systematically analyze the results to determine the effectiveness of the reduced port approach.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and recovery for patients undergoing gastrectomy for gastric cancer.

How similar studies have gone: While reduced port laparoscopic techniques are gaining traction, systematic evaluations comparing them to traditional methods are still limited, making this study a potentially novel contribution.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages.
2. Eastern Cooperative Oncology Group performance status of 0 or 1.
3. Adequate organ function.

Exclusion Criteria:

1. Patients had distant metastasis.
2. oesophageal invasion of more than 3 cm.
3. Borrmann type 4 or large (more than 8 cm) type 3 carcinoma.
4. Previous chemotherapy or radiation therapy for any other malignancies.

Where it's running

  • Yunhong Tian
    Nanchong, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.